Ann M. Geiger

Ann M. Geiger

Auto-generated profile, based on publicly available information

Ann M. Geiger

Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2019 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
LNLarissa Nekhlyudov
Larissa Nekhlyudov
MMMichelle A Mollica
Michelle A Mollica
PJPaul B Jacobsen
Paul B Jacobsen
DMDeborah K Mayer
Deborah K Mayer
LSLawrence N Shulman
Lawrence N Shulman
AGAnn M Geiger
Ann M Geiger
There are now close to 17 million cancer survivors in the United States, and this number is expected to continue to grow. One decade ago the Institute of Medicine report, From Cancer Patient to Cancer Survivor: Lost in Transition, outlined 10 recommendations aiming to provide coordinated, comprehensive care for cancer survivors. Although there has been noteworthy progress made since the release of the report, gaps remain in research, clinical practice, and policy. Specifically, the recommendation calling for the development of quality measures in cancer survivorship care has yet to be fulfilled. In this commentary, we describe the development of a comprehensive, evidence-based cancer survivorship care quality framework and propose the next steps to systematically apply it in clinical settings, research, and policy.

8 October 2019 in Cancer
Verified
Journal Article
Closed access
PDF file
EKErin Kent
Erin Kent
CWChristopher W. Wheldon
Christopher W. Wheldon
ASAshley Wilder Smith
Ashley Wilder Smith
SSShobha Srinivasan
Shobha Srinivasan
AGAnn M. Geiger
Ann M. Geiger

9 April 2021 in JNCI Cancer Spectrum
Verified
Journal Article
Open access
PDF file
JMJanet S de Moor
Janet S de Moor
MMMichelle Mollica
Michelle Mollica
ASAnnie Sampson
Annie Sampson
BABrenda Adjei
Brenda Adjei
SWSallie J Weaver
Sallie J Weaver
HCHenry P Ciolino
Henry P Ciolino
Background: Cancer Centers have a responsibility to help patients manage the costs of their cancer treatment. This article describes the availability of financial navigation services within the National Cancer Institute (NCI)-Designated Cancer Centers. Methods: Data were obtained from the NCI Survey of Financial Navigation Services and Research, an online survey administered to NCI-Designated Cancer Centers from July to September 2019. Of the 62 eligible Centers, 57 completed all or most of the survey, for a response rate of 90.5%. Results: Nearly all Cancer Centers reported providing help with applications for pharmaceutical assistance programs and medical discounts (96.5%), health insurance coverage (91.2%), assistance with non-medical costs (96.5%), and help understanding medical bills and out-of-pocket costs (85.9%). Although other services were common, in some cases they were only available to certain patients. These services included direct financial assistance with medical and non-medical costs and referrals to outside organizations for financial assistance. The least common services included medical debt management (63.2%), detailed discussions about the cost of treatment (54.4%), and guidance about legal protections (50.1%). Providing treatment cost transparency to patients was reported as a common challenge: 71.9% of Centers agreed or strongly agreed that it is difficult to determine how much a cancer patient’s treatment will cost and 70.2% of oncologists are reluctant to discuss financial issues with patients. Conclusions: Cancer Centers provide many financial services and resources. However, there remains a need to build additional capacity to deliver comprehensive financial navigation services and to understand the extent to which patients are referred and helped by these services.

3 December 2020 in Blood
Verified
Journal Article
Open access
PDF file
MSMohammed Saad
Mohammed Saad
KLKah Poh Loh
Kah Poh Loh
JTJanet Tooze
Janet Tooze
TPTimothy S. Pardee
Timothy S. Pardee
LELeslie R. Ellis
Leslie R. Ellis
HKHeidi Klepin
Heidi Klepin

18 June 2014 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
JJJennifer H. Jordan
Jennifer H. Jordan
STSoe Soe Thwin
Soe Soe Thwin
TLTimothy L. Lash
Timothy L. Lash
DBDiana S. M. Buist
Diana S. M. Buist
TFTerry S. Field
Terry S. Field
AGAnn M. Geiger
Ann M. Geiger

1 June 2020 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
AGAnn M Geiger
Ann M Geiger
AOAnn M O’mAra
Ann M O’mAra
WMWorta J McCaskill-Stevens
Worta J McCaskill-Stevens
BABrenda Adjei
Brenda Adjei
PTPriyanga Tuovenin
Priyanga Tuovenin
KCKathleen M Castro
Kathleen M Castro
Research seeking to improve patient engagement with decision-making, use of evidence-based guidelines, and coordination of multi-specialty care has made important contributions to the decades-long effort to improve cancer care. The National Cancer Institute expanded support for these efforts by including cancer care delivery research in the 2014 formation of the National Cancer Institute Community Oncology Research Program (NCORP). Cancer care delivery research is a multi-disciplinary effort to generate evidence-based practice change that improves clinical outcomes and patient well-being. NCORP scientists and community-based clinicians and organizations rapidly embraced the addition of this type of research into the network, resulting in a robust portfolio of observational studies and intervention studies within the first 5 years of funding. This commentary describes the initial considerations in conducting this type of research in a network previously focused on cancer prevention, control, and treatment studies; characterizes the protocols developed to date; and outlines future directions for cancer care delivery research in the second round of NCORP funding.